Possible sepsis treatment needs additional evidence

Paul Marik, MD, an intensive care surgeon at the Eastern Virginia Medical School in Norfolk, claims he has been able to treat sepsis, the leading cause of death for patients in the hospital, in 150 patients with only one fatality.

Marik's proposed treatment involves an intravenous mix of corticosteroids, vitamins B and C, paired with precise management of fluids. While he says “extraordinary evidence” backs his treatment, others are calling for more research.

"Nothing has worked despite all the great ideas people have had, often ballyhooed with observational data like this, claiming that it's a big effect," said Robert Califf, MD, who recently returned to Duke University after running the U.S. Food and Drug Administration.

Read the full story by clicking the link below:

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

Given the precarious excitement of the moment—or is it exciting precarity?—policymakers and healthcare leaders must set directives guiding not only what to do with AI but also when to do it. 

The final list also included diabetes drugs sold by Boehringer Ingelheim and Merck. The first round of drug price negotiations reduced the Medicare prices for 10 popular drugs by up to 79%. 

HHS has thought through the ways AI can and should become an integral part of healthcare, human services and public health. Last Friday—possibly just days ahead of seating a new secretary—the agency released a detailed plan for getting there from here.